BioXcel Therapeutics, Inc. (BTAI)
1.60
-0.03
(-1.84%)
USD |
NASDAQ |
Mar 03, 16:00
1.48
-0.12
(-7.50%)
After-Hours: 05:09
BioXcel Therapeutics Research and Development Expense (Annual) : 29.19M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Rigel Pharmaceuticals, Inc. | 23.38M |
| Puma Biotechnology, Inc. | 62.07M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 78.03M |